D10 Metabolic and thermal monitoring

Topic

Continuous metabolic monitoring of the critically ill patient primarily involves tracking glucose levels, core temperature, and hourly urine output. These variables allow for the dynamic assessment of metabolic status, perfusion, and renal function, enabling the early detection of abnormalities that may require intervention.

Glucose levels can be monitored using subcutaneous electrochemical sensors that measure concentration in the interstitial fluid. Because glucose must diffuse from the capillaries into this compartment, there is a lag of approximately 5–15 minutes relative to blood glucose levels. By connecting this sensor to an insulin pump and an algorithm that automatically adjusts delivery based on recent glucose trends, a closed-loop system—or artificial pancreas—can be created. According to the text, this system can maintain blood glucose levels between 3.9 and 10 mmol/L without the need for continuous manual adjustments. To operate safely, the sensor must exhibit an average error rate of less than 10%, as larger errors could lead to inappropriate insulin administration.

Core temperature reflects the body's thermoregulatory status. A temperature above 38.3°C indicates an active inflammatory response, whereas a temperature below 36°C in a patient with sepsis is a sign of severity associated with thermoregulatory failure. Comparing core temperature with skin temperature is also useful. A difference greater than 7°C reflects intense peripheral vasoconstriction and can predict low cardiac output—particularly following cardiac surgery—as the body reduces cutaneous circulation to preserve blood flow to vital organs.

Hourly urine output provides immediate information regarding perfusion and renal function. Urine output of less than 0.5 mL/kg/h sustained for more than two hours indicates insufficient production and, according to the text, constitutes a criterion for acute kidney injury. To determine whether oliguria stems primarily from reduced blood flow to a still-functional kidney or from established renal injury, one can calculate the fraction of filtered sodium that is ultimately excreted in the urine. A fractional excretion of less than 1% indicates that the kidney retains its ability to conserve sodium in the face of reduced circulating volume; higher values ​​suggest a loss of this capacity due to renal injury. When a patient is receiving diuretics—which directly alter sodium excretion—it is more useful to apply similar reasoning using the fractional excretion of urea.

Fluid balance is another key variable. It is calculated by summing all administered fluids and subtracting all losses incurred during the intensive care stay. An excessively positive cumulative balance indicates volume overload. According to the text, a cumulative positive balance exceeding approximately 10 liters during the first week is independently associated with higher mortality and a longer duration of mechanical ventilation.

This calculation must also account for insensible water losses through the skin and respiratory tract, which typically range from 500 to 800 mL per day. These losses increase by approximately 100 to 150 mL per day for every degree of fever. In patients with sepsis, following the initial fluid resuscitation phase, achieving a moderately negative balance is associated with a more favorable renal outcome, whereas excessive fluid accumulation constitutes a risk factor.

Taken together, these variables provide a dynamic overview of the critically ill patient's status. Continuous glucose monitoring allows for the rapid detection and correction of hypoglycemia and hyperglycemia; core temperature and the temperature gradient between the core and the skin provide information on inflammation, thermoregulation, and peripheral perfusion; urine output and fractional excretion rates help distinguish between reduced renal perfusion and established injury; and fluid balance enables the detection of progressive volume overload.

When integrated on an hourly basis, these measurements allow for the simultaneous monitoring of metabolism, circulation, and renal function. Thus, continuous metabolic monitoring is not limited to recording isolated values; instead, it uses their temporal evolution to anticipate deterioration and guide adjustments to insulin, fluids, and other supportive measures before abnormalities become clinically evident.

ID:2283